{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:19:47Z","timestamp":1761488387293,"version":"3.37.3"},"reference-count":73,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.transci.2010.01.009","type":"journal-article","created":{"date-parts":[[2010,2,11]],"date-time":"2010-02-11T11:54:22Z","timestamp":1265889262000},"page":"141-150","source":"Crossref","is-referenced-by-count":12,"title":["Lymphoma \u2013 Emerging realities in sub-Saharan Africa"],"prefix":"10.1016","volume":"42","author":[{"given":"Gerhard","family":"Sissolak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"June","family":"Juritz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dagmar","family":"Sissolak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucille","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2010.01.009_bib1","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":"Revised response criteria for malignant lymphoma. The international harmonization project on lymphoma","volume":"25","author":"Cheson","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2010.01.009_bib2","first-page":"231","article-title":"Lymphoma 2006: classification and treatment","volume":"20","author":"Armitage","year":"2006","journal-title":"Oncology"},{"key":"10.1016\/j.transci.2010.01.009_bib3","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/10428190400019891","article-title":"Hodgkin\u2019s lymphoma and tuberculosis coexistence in cervical lymph nodes","volume":"46","author":"Centkowski","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.transci.2010.01.009_bib4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.transci.2007.04.010","article-title":"AIDS defining lymphomas in the era of highly active antiretroviral therapy (HAART): an African perspective","volume":"37","author":"Sissolak","year":"2007","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.transci.2010.01.009_bib5","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/PAP.0b013e318159479d","article-title":"The critical role of histology in an era of genomics and proteomics: a commentary and reflection","volume":"14","author":"Nathwani","year":"2007","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.transci.2010.01.009_bib6","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.blre.2004.11.003","article-title":"Microarray-based gene expression profiling of hematologic malignancies: basic concepts and clinical applications","volume":"19","author":"Margalit","year":"2005","journal-title":"Blood Rev"},{"key":"10.1016\/j.transci.2010.01.009_bib7","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.1182\/blood-2008-07-077982","article-title":"Classification of lymphoid neoplasms: the microscope as a tool for disease discovery","volume":"112","author":"Jaffe","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.transci.2010.01.009_bib8","first-page":"315","article-title":"Computer tomographic evaluation of digestive tract non-Hodgkin\u2019s lymphomas","volume":"16","author":"Lupescu","year":"2007","journal-title":"J Gastrointest Liver Dis"},{"key":"10.1016\/j.transci.2010.01.009_bib9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s12149-007-0015-1","article-title":"Diagnostic performance of CT, PET, side-by-side, and fused image interpretations for restaging of non-Hodgkin lymphoma","volume":"21","author":"Nogami","year":"2007","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.transci.2010.01.009_bib10","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1365-2141.2006.06284.x","article-title":"Positron emission tomography\/computed tomography: diagnostic accuracy in lymphoma","volume":"135","author":"Hernandez-Maraver","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2010.01.009_bib11","doi-asserted-by":"crossref","first-page":"497","DOI":"10.5858\/2005-129-497-CORVOB","article-title":"Comparison of relative value of bone marrow aspirates and bone marrow trephine biopsies in the diagnosis of solid tumor metastasis and Hodgkin lymphoma: institutional experience and literature review","volume":"129","author":"Moid","year":"2005","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.transci.2010.01.009_bib12","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/bjc.1990.328","article-title":"The Cotswolds report on the investigation and staging of Hodgkin\u2019s disease","volume":"62","author":"Crowther","year":"1990","journal-title":"Br J Cancer"},{"doi-asserted-by":"crossref","unstructured":"A predictive model for aggressive non-Hodgkin\u2019s lymphoma. The International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project. N Engl J Med 1994;329:987\u201394.","key":"10.1016\/j.transci.2010.01.009_bib13","DOI":"10.1056\/NEJM199309303291402"},{"key":"10.1016\/j.transci.2010.01.009_bib14","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1080\/10428190600757894","article-title":"The International Prognostic Index predicts outcome after histological transformation of low-grade non-Hodgkin lymphoma","volume":"47","author":"Micallef","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.transci.2010.01.009_bib15","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1182\/blood-2003-12-4434","article-title":"Follicular lymphoma international prognostic index","volume":"104","author":"Solal-Celigny","year":"2004","journal-title":"Blood"},{"unstructured":"In: 47th annual meeting of the American society of hematology, Atlanta, Georgia, December 2005. Benefit of induction and maintenance rituximab therapy in relapsed\/resistant follicular NHL: final results of the EORTC 20981 trial. Clin Lymphoma Myeloma 2006;6:264\u20135.","key":"10.1016\/j.transci.2010.01.009_bib16"},{"key":"10.1016\/j.transci.2010.01.009_bib17","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1080\/07357900600981414","article-title":"Alemtuzumab in CLL and other lymphoid neoplasms","volume":"24","author":"Ravandi","year":"2006","journal-title":"Cancer Invest"},{"key":"10.1016\/j.transci.2010.01.009_bib18","first-page":"203","article-title":"Novel concepts in radioimmunotherapy for non-Hodgkin\u2019s lymphoma","volume":"12","author":"Schaefer-Cutillo","year":"2007","journal-title":"Oncology"},{"issue":"Suppl. 2","key":"10.1016\/j.transci.2010.01.009_bib19","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1053\/j.seminhematol.2005.12.006","article-title":"Purine analogue combinations for indolent lymphomas","volume":"43","author":"Di Bella","year":"2006","journal-title":"Semin Hematol"},{"key":"10.1016\/j.transci.2010.01.009_bib20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.transci.2007.04.009","article-title":"Use of novel proteasome inhibitors as a therapeutic strategy in lymphomas: current experience and emerging concepts","volume":"37","author":"Abayomi","year":"2007","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.transci.2010.01.009_bib21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/cncr.22389","article-title":"Experience with heat shock protein\u2013peptide complex 96 vaccine therapy in patients with indolent non-Hodgkin lymphoma","volume":"109","author":"Oki","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.transci.2010.01.009_bib22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.transci.2004.10.001","article-title":"Lymphoma \u2013 the immune system in disarray. Theme for the 11th congress of the South African Lymphoma Study Group meeting","volume":"32","author":"Jacobs","year":"2005","journal-title":"Transfus Apher Sci"},{"unstructured":"Jacobs P, Wood L, Ruff P. Hodgkin lymphoma in developing countries: an African perspective with a note on Asia and Latin America. In: Hoppe RT, Mauch PT, Armitage JO, Diehl V, Weiss LM, editors. Hodgkin lymphoma. 2nd ed. Philadelphia: Williams & Wilkins; 2007. p. 427\u201348.","key":"10.1016\/j.transci.2010.01.009_bib23"},{"key":"10.1016\/j.transci.2010.01.009_bib24","first-page":"135","article-title":"Lymphoma \u2013 histopathology in changing clinical perspective","volume":"90","author":"Jacobs","year":"2000","journal-title":"S Afr Med J"},{"doi-asserted-by":"crossref","unstructured":"Jacobs P, Wood L, Armitage JO. In: Proceedings of the 12th biennial congress \u2013 South African Lymphoma Study Group. Transfus Apher Sci 2007;37:27\u20139.","key":"10.1016\/j.transci.2010.01.009_bib25","DOI":"10.1016\/j.transci.2007.04.007"},{"key":"10.1016\/j.transci.2010.01.009_bib26","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood.V46.2.219.219","article-title":"Clinical staging of chronic lymphocytic leukemia","volume":"46","author":"Rai","year":"1975","journal-title":"Blood"},{"key":"10.1016\/j.transci.2010.01.009_bib27","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1182\/blood-2007-06-095331","article-title":"A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma","volume":"111","author":"Hoster","year":"2008","journal-title":"Blood"},{"issue":"Suppl. 1","key":"10.1016\/j.transci.2010.01.009_bib28","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1038\/bmt.2008.140","article-title":"Immunohematopoietic stem cell transplantation: introduction and 35 years of development in South Africa \u2013 the historical and scientific perspective","volume":"42","author":"Jacobs","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transci.2010.01.009_bib29","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/hon.743","article-title":"Radiation therapy for localized low-grade non-Hodgkin\u2019s lymphomas","volume":"23","author":"Tsang","year":"2005","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.transci.2010.01.009_bib30","doi-asserted-by":"crossref","first-page":"8018","DOI":"10.1200\/JCO.2005.02.3903","article-title":"Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication","volume":"23","author":"W\u00fcndisch","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2010.01.009_bib31","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/j.1572-0241.2003.07424.x","article-title":"Gastric mucosa-associated lymphoid tissue lymphoma","volume":"98","author":"Ahmad","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.transci.2010.01.009_bib32","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1200\/JCO.2003.07.133","article-title":"Treatment of indolent B-cell nonfollicular lymphomas: final results of the LL01 randomized trial of the Gruppo Italiano per lo Studio dei Linfomi","volume":"21","author":"Baldini","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2010.01.009_bib33","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2307\/2281868","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.transci.2010.01.009_bib34","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc B"},{"unstructured":"UNAIDS. 2006 report on the global AIDS epidemic: executive summary. A UNAIDS 10th anniversary special edition. Geneva: UNAIDS; 2006.","key":"10.1016\/j.transci.2010.01.009_bib35"},{"key":"10.1016\/j.transci.2010.01.009_bib36","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1023\/A:1008265532487","article-title":"Epidemiology of the non-Hodgkin\u2019s lymphomas: distributions of the major subtypes differ by geographic locations. The non-Hodgkin\u2019s lymphoma classification project","volume":"9","author":"Anderson","year":"1998","journal-title":"Ann Oncol"},{"doi-asserted-by":"crossref","unstructured":"A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin\u2019s lymphoma. The non-Hodgkin\u2019s lymphoma classification project. Blood 1997;89:3909\u201318.","key":"10.1016\/j.transci.2010.01.009_bib37","DOI":"10.1182\/blood.V89.11.3909"},{"key":"10.1016\/j.transci.2010.01.009_bib38","first-page":"3310","article-title":"Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of Anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. The German\u2013Austria\u2013Swiss ALL-BFM Study Group","volume":"95","author":"Schrappe","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.transci.2010.01.009_bib39","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1182\/blood-2006-10-041863","article-title":"How I treat indolent lymphoma","volume":"109","author":"Gribben","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.transci.2010.01.009_bib40","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1182\/blood-2004-08-3175","article-title":"CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma","volume":"105","author":"Marcus","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.transci.2010.01.009_bib41","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-2141.2007.06746.x","article-title":"Low-dose oral fludarabine plus cyclophosphamide as first-line treatment in elderly patients with indolent non-Hodgkin lymphoma","volume":"139","author":"Fabbri","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2010.01.009_bib42","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1046\/j.1365-2141.2002.03959.x","article-title":"Fludarabine, cyclophosphamide and mitoxantrone in the treatment of resistant or relapsed chronic lymphocytic leukaemia","volume":"119","author":"Bosch","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2010.01.009_bib43","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1182\/blood-2004-04-1323","volume":"104","author":"Forstpointner","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.transci.2010.01.009_bib44","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/sj.thj.6200323","article-title":"A review of recruitment criteria, patient characteristics and results of CHOP chemotherapy in prospective randomized phase III clinical trials for aggressive non-Hodgkin\u2019s lymphoma","volume":"4","author":"van Agthoven","year":"2003","journal-title":"Hematol J"},{"key":"10.1016\/j.transci.2010.01.009_bib45","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1200\/JCO.2005.05.1003","article-title":"Rituximab\u2013CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma","volume":"24","author":"Habermann","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2010.01.009_bib46","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1200\/JCO.2003.09.542","article-title":"High response rates and lasting remissions after low-dose involved field radiotherapy in indolent lymphomas","volume":"21","author":"Haas","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2010.01.009_bib47","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1200\/JCO.1998.16.9.3007","article-title":"Treatment of hairy cell leukaemia with 2-chlorodeoxyadenosine via the Group C protocol mechanism of the National Cancer Institute: a report of 979 patients","volume":"16","author":"Cheson","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2010.01.009_bib48","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1046\/j.0007-1048.2002.03362.x","article-title":"High-dose chlorambucil for the treatment of chronic lymphocytic leukaemia and low-grade non-Hodgkin\u2019s lymphoma","volume":"116","author":"Summerfield","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2010.01.009_bib49","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1200\/JCO.2004.10.086","article-title":"Stage I and II follicular non-Hodgkin\u2019s lymphoma: long-term follow-up of no initial therapy","volume":"22","author":"Advani","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2010.01.009_bib50","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1200\/JCO.1993.11.4.644","article-title":"Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoimmunotherapy","volume":"11","author":"Dana","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2010.01.009_bib51","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1182\/blood-2006-05-021113","article-title":"Rituximab maintenance improves clinical outcome of relapsed\/resistant follicular non-Hodgkin lymphoma in patients both with and without rituximab during induction: results of a prospective randomized phase 3 intergroup trial","volume":"108","author":"Van Oers","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.transci.2010.01.009_bib52","first-page":"282","article-title":"Fludarabine in combination with cyclophosphamide or with cyclophosphamide plus mitoxantrone for relapsed or refractory low-grade non-Hodgkin\u2019s lymphoma","volume":"86","author":"Santini","year":"2001","journal-title":"Haematologica"},{"doi-asserted-by":"crossref","unstructured":"Dreyling M, Forstpointner R, Gramatzki M, B\u00f6ck H, H\u00e4nel M, Seymour J, et al. Rituximab maintenance improves progression-free and overall survival rates after combined immuno-chemotherapy (R-FCM) in patients with relapsed follicular and mantle cell lymphoma: final results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG). J Clin Oncol 2006;Suppl. 24 [Abstr 7502].","key":"10.1016\/j.transci.2010.01.009_bib53","DOI":"10.1200\/jco.2006.24.18_suppl.7502"},{"key":"10.1016\/j.transci.2010.01.009_bib54","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1182\/blood.V71.1.117.117","article-title":"Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP)","volume":"71","author":"Velasquez","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.transci.2010.01.009_bib55","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1056\/NEJM199304083281404","article-title":"Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin\u2019s lymphoma","volume":"328","author":"Fisher","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transci.2010.01.009_bib56","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1182\/blood-2005-01-0016","volume":"106","author":"Hiddemann","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.transci.2010.01.009_bib57","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3324\/haematol.11671","article-title":"High clinical and molecular response rates with fludarabine, cyclophosphamide and mitoxantrone in previously untreated patients with advanced stage follicular lymphoma","volume":"93","author":"Montoto","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.transci.2010.01.009_bib58","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1200\/JCO.1998.16.12.3803","article-title":"Hyper-CVAD and high-dose methotrexate\/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma","volume":"16","author":"Khouri","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2010.01.009_bib59","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma","volume":"346","author":"Coiffier","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transci.2010.01.009_bib60","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1182\/blood-2003-06-2094","article-title":"Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL","volume":"104","author":"Pfreundschuh","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.transci.2010.01.009_bib61","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1182\/blood-2003-11-3911","article-title":"Rituximab and ICE as second-line therapy before autologous stem cell transplantation for elapsed or primary refractory diffuse large B-cell lymphoma","volume":"103","author":"Kewalramani","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.transci.2010.01.009_bib62","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1093\/annonc\/mdf253","article-title":"An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt\u2019s lymphoma: results of United Kingdom Lymphoma Group LY06 study","volume":"13","author":"Mead","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1016\/j.transci.2010.01.009_bib63","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3109\/10428199709109162","article-title":"2-Chlorodeoxyadenosine in cutaneous T-cell lymphoproliferative disorders","volume":"26","author":"Kong","year":"1997","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.transci.2010.01.009_bib64","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1182\/blood-2005-03-1306","article-title":"T-cell non-Hodgkin lymphoma","volume":"107","author":"Rizvi","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.transci.2010.01.009_bib65","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1046\/j.1365-2141.2001.02743.x","article-title":"Treatment of refractory T-cell malignancies using gemcitabine","volume":"113","author":"Sallah","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2010.01.009_bib66","first-page":"1680","article-title":"Current treatment and immunotherapy of Hodgkin\u2019s lymphoma","volume":"90","author":"Klimm","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.transci.2010.01.009_bib67","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1634\/theoncologist.11-3-263","article-title":"Large granular lymphocyte leukemia","volume":"11","author":"Sokol","year":"2006","journal-title":"Oncologist"},{"key":"10.1016\/j.transci.2010.01.009_bib68","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/annonc\/mdi003","article-title":"Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma: results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG)","volume":"16","author":"Josting","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.transci.2010.01.009_bib69","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3816\/CLM.2002.n.015","article-title":"Gemcitabine and its combinations in the treatment of malignant lymphoma","volume":"3","author":"Chau","year":"2002","journal-title":"Clin Lymphoma"},{"issue":"Suppl.","key":"10.1016\/j.transci.2010.01.009_bib70","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1385\/MO:19:2S:S27","article-title":"Alemtuzumab in T-cell malignancies","volume":"19","author":"Dearden","year":"2002","journal-title":"Med Oncol"},{"key":"10.1016\/j.transci.2010.01.009_bib71","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/cncr.20999","article-title":"Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma: the M.D. Anderson Cancer Center experience","volume":"103","author":"Escal\u00f3n","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.transci.2010.01.009_bib72","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1200\/JCO.1998.16.1.19","article-title":"MOPP\/ABV hybrid chemotherapy for advanced Hodgkin\u2019s disease significantly improves failure-free and overall survival: the 8-year results of the intergroup trial","volume":"16","author":"Oken","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2010.01.009_bib73","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1200\/JOP.0758501","article-title":"How I treat mantle cell lymphoma","volume":"3","author":"Straus","year":"2007","journal-title":"J Oncol Pract"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050210000108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050210000108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T09:49:32Z","timestamp":1739872172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050210000108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":73,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S1473050210000108"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2010.01.009","relation":{},"ISSN":["1473-0502"],"issn-type":[{"type":"print","value":"1473-0502"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}